Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06335173
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-03-13
Brief Title:
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimers Disease ALTITUDE-AD
Sponsor:
Acumen Pharmaceuticals
Organization:
Acumen Pharmaceuticals
Organization Data
Organization:
Acumen Pharmaceuticals
Class:
INDUSTRY
Study ID:
ACU193-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Acumen Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None